22/12/2016 09:14:00

Transaction in Own Shares

Related content
14 Jun - 
Director/PDMR Shareholding
26 May - 
Director/PDMR Shareholding
25 May - 
Transaction in Own Shares

PENDRAGON PLC - Transaction in Own Shares

PR Newswire

Pendragon PLC: Transaction in Own Shares

Pendragon PLC (the “Company”) announces that it has purchased for cancellation (through Jefferies International Limited) the following number of its ordinary shares of 5p each on the London Stock Exchange.

Date of purchase:21 December 2016
Number of ordinary shares purchased (aggregated volume):74,049
Highest price paid per share (pence):31.00p
Lowest price paid per share (pence):30.75p
Volume weighted average price paid per share (pence):        30.7699p

Following the purchase of these shares, the Company has 1,437,126,107 ordinary shares in issue. All of the shares have equal voting rights and there are no shares held in treasury.  This figure 1,437,126,107 represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority’s Disclosure and Transparency Rules.

The schedule below contains detailed information about the purchases made by Jefferies on behalf of the Company as part of the buyback programme.

HILARY C SYKES

COMPANY SECRETARY

21 DECEMBER 2016

Schedule of Purchases – Individual Transactions

Number of shares purchased

Transaction price

(pence per share)

Time of transaction

Trading venue

3971

30.75

16:29:15

London Stock Exchange

2217

30.75

16:27:42

London Stock Exchange

1276

30.75

16:27:42

London Stock Exchange

3203

30.75

16:20:57

London Stock Exchange

3195

30.75

16:12:57

London Stock Exchange

3372

30.75

16:10:47

London Stock Exchange

10209

30.75

16:10:40

London Stock Exchange

6986

30.75

16:10:36

London Stock Exchange

2815

30.75

15:53:58

London Stock Exchange

126

30.75

15:53:58

London Stock Exchange

3330

30.75

15:41:18

London Stock Exchange

2960

30.75

15:04:41

London Stock Exchange

6178

30.75

14:19:21

London Stock Exchange

11980

30.75

14:19:17

London Stock Exchange

3147

30.75

14:00:08

London Stock Exchange

3182

30.75

13:55:00

London Stock Exchange

5902

31

12:02:19

London Stock Exchange

-ENDS-

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Regulatory news

Alliance Trust PLC : Transaction in Own Shares

14/06/2017 07:00:13
14 June 2017  Alliance Trust PLC TRANSACTION IN OWN SHARES  The Board of Alliance Trust PLC ("the Company") announces that on 13 June 2017 the Company purchased for cancellation 209,000 ordinary shares of 2.5p each at a price of 708.0748p per share.  Therefore, the total number of voting rights in the Company is now 354,575,762.    The above figure (354,575,762) may be used by shareholder..

Majedie Asset Management Ltd : Form 8.3 - TESCO PLC

13/06/2017 15:20:46
FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of discloser: ..

Quarterly Update for the Quarter to 30 April 2017

13/06/2017 12:50:10
13 June 2017 ICG Enterprise Trust Plc Quarterly Update For the quarter to 30 April 2017 Highlights Share price Total Return1 of 5.7% for the quarter and 39.9% for the 12 months to 30 April 2017 Net asset value per share Total Return1 of 0.6% for the quarter and 19.9% for the 12 months The Portfolio1 is valued at £54..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Rubicon Hires Former SAP Ariba Executive as CFO
2
Philips to acquire The Spectranetics Corporation to accelerate expansion in image-guided therapy devices to treat cardiac and peripheral vascular disease
3
Ramirent renews multi-year equipment rental frame agreement with Meyer Turku Oy’s shipyard in Finland
4
LogicBio Therapeutics Announces $50 Million in Financing to Develop Novel Gene Medicines for Pediatric Patients
5
Arix Bioscience leads $45 million Series B financing round into LogicBio Therapeutics

Related stock quotes

Pendragon PLC ORD 5P 31.25 0.0% Stock price unchanged

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
29 June 2017 03:09:58
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20170623.1 - EUROWEB2 - 2017-06-29 04:09:58 - 2017-06-29 03:09:58 - 1000 - Website: OKAY